COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,556 Articles (22,881 medRxiv, 8,675 bioRxiv)

Most recent first Previous |  Page 1257: Articles 12561-12570  | Next

Unusual SARS-CoV-2 intra-host diversity reveals lineages superinfection
Dezordi, F. Z., Resende, P. C., Naveca, F. G., do Nascimento, V. A., de Souza, V. C., Paixao, A. C. D., Appolinario, L., Lopes, R. S., Mendonca, A. C. d. F., da Rocha, A. S. B., Venas, T. M. M., Pereira, E. C., Salvato, R. S., Gregianini, T. S., Martins, L. G., Pereira, F. M., Rovaris, D. B., Fernandes, S. B., Ribeiro-Rodrigues, R., Costa, T. O., Sousa, J. C., Miyajima, F., Delatorre, E., Graf, T., Bello, G., Siqueira, M. M., Wallau, G. L.
10.1101/2021.09.18.21263755 — Posted: 2021-09-23
Divergence of delta and beta variants and SARS-CoV-2 evolved in prolonged infection into distinct serological phenotypes
Cele, S., Karim, F., Lustig, G., James, S. E., Hermanus, T., Wilkinson, E., Snyman, J., Bernstein, M., Khan, K., Hwa, S.-H., Tegally, H., Tilles, S. W., Giandhari, J., Mthabela, N., Mazibuko, M., Ganga, Y., Gosnell, B. I., Karim, S. A., Hanekom, W., Van Voorhis, W. C., Ndungu, T., Lessells, R. J., Moore, P. L., Moosa, M.-Y. S., de Oliveira, T., Sigal, A.
10.1101/2021.09.14.21263564 — Posted: 2021-09-23
Financial and Non-financial Conflicts of Interest Among the Japanese Government Advisory Board Members Concerning Coronavirus Disease 2019
Mamada, H., Murayama, A., Ozaki, A., Hashimoto, T., Saito, H., Sawano, T., Bhandari, D., Shrestha, S., Tanimoto, T.
10.1101/2021.09.12.21263442 — Posted: 2021-09-23
Saliva-based detection of COVID-19 infection in a real-world setting using reagent-free Raman spectroscopy and machine learning
Ember, K. J. I., Daoust, F., Mahfoud, M., Dallaire, F., Zamani, E., Tran, T., Plante, A., Diop, M.-K., Nguyen, T., St-Georges-Robillard, A., Ksantini, N., Lanthier, J., Filiatrault, A., Sheehy, G., Quach, C., Trudel, D., Leblond, F.
10.1101/2021.09.21.21262619 — Posted: 2021-09-23
Colchicine for COVID-19 in adults in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
The PRINCIPLE Trial Collaborative Group, , Dorward, J., Yu, L.-M., Hayward, G., Saville, B. R., Gbinigie, O., van Hecke, O., Ogburn, E., Evans, P. H., Thomas, N. P., Patel, M. G., Richards, D., Berry, N., Detry, M. A., Saunders, C., Fitzgerald, M., Harris, V., Shanyinde, M., de Lusignan, S., Andersson, M. I., Butler, C. C., Hobbs, F. R.
10.1101/2021.09.20.21263828 — Posted: 2021-09-23
Comparative analysis of human immune responses following SARS-CoV-2 vaccination with BNT162b2, mRNA-1273, or Ad26.COV2.S
Barbeau, D., Martin, J., Carney, E., Dougherty, E., Doyle, J., Dermody, T., Hoberman, A., Williams, J., Michaels, M., Alcorn, J., Duprex, P., McElroy, A. K.
10.1101/2021.09.21.21262927 — Posted: 2021-09-23
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine in people living with HIV-1
Feng, Y., Zhang, Y., He, Z., Huang, H., Tian, X., Wang, G., Chen, D., Ren, Y., Jia, L., Wang, W., Wu, J., Shao, L., Zhang, W., Tang, H., Wan, Y.
10.1101/2021.09.14.21263556 — Posted: 2021-09-22
A system biology approach identifies candidate drugs to reduce mortality in severely ill COVID-19 patients
Fava, V. M., Bourgey, M., Nawarathna, P. M., Orlova, M., Cassart, P., Vinh, D. C., Cheng, M. P., Bourque, G., Schurr, E., Langlais, D.
10.1101/2021.09.14.21262309 — Posted: 2021-09-22
Monitoring the COVID-19 immunisation programme through a National Immunisation Management System- Englands experience
Tessier, E., Stowe, J., Tsang, C., Rai, Y., Clarke, E., Lakhani, A., Makwana, A., Heard, H., Rickeard, T., Kirsebom, F., Quinot, C., Lakhani, S., Power, L., Edelstein, M., Evans, A., Ramsay, M., Lopez Bernal, J., White, J., Gower, C., Andrews, N., Campbell, C.
10.1101/2021.09.14.21263578 — Posted: 2021-09-22
Information Theoretic Model Selection for Accurately Estimating Unreported COVID-19 Infections
Cui, J., Haddadan, A., Haque, A. S. M. A.-U., Adhikari, B., Vullikanti, A., Prakash, B. A.
10.1101/2021.09.14.21263467 — Posted: 2021-09-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).